|
|
Résultats pour
brevets
1.
|
Hypoestoxide, derivatives, related compounds, and agonists thereof for treatment or prevention of neurodegenerative diseases
| Numéro d'application |
15556730 |
| Numéro de brevet |
10857122 |
| Statut |
Délivré - en vigueur |
| Date de dépôt |
2016-02-03 |
| Date de la première publication |
2018-04-19 |
| Date d'octroi |
2020-12-08 |
| Propriétaire |
IMMUNE MODULATION, INC. (USA)
|
| Inventeur(s) |
- Cottam, Howard
- Ojo-Amaize, Emmanuel
- Nchekwube, Emeka
- Oyemade, Olusola
|
Abrégé
New uses of hypoestoxide, its derivatives and related compounds for treatment and prevention of neurodegenerative diseases (e.g. Parkinsons disease, Alzheimers disease, Huntingtons disease) are described. More specifically, the invention relates to methods for treating various neurodegenerative diseases through administration of hypoestoxide, its derivatives and related compounds, or a combination thereof to a subject with a neurodegenerative disease such that the symptoms of the disease are treated or at least partially alleviated. Furthermore, the present invention further provides methods of preventing the development of neurodegenerative diseases in individuals who are predisposed to developing a neurodegenerative disease over time.
Classes IPC ?
- A61K 31/336 - Composés hétérocycliques ayant l'oxygène comme seul hétéro-atome d'un cycle, p. ex. fungichromine ayant des cycles à trois chaînons, p. ex. oxirane, fumagilline
- A61P 25/16 - Antiparkinsoniens
- C07D 493/04 - Systèmes condensés en ortho
|
2.
|
HYPOESTOXIDE, DERIVATIVES, RELATED COMPOUNDS, AND AGONISTS THEREOF FOR TREATMENT OR PREVENTION OF NEURODEGENERATIVE DISEASES
| Numéro de document |
02978869 |
| Statut |
Délivré - en vigueur |
| Date de dépôt |
2016-02-03 |
| Date de disponibilité au public |
2016-09-15 |
| Date d'octroi |
2023-09-19 |
| Propriétaire |
IMMUNE MODULATION, INC. (USA)
|
| Inventeur(s) |
- Cottam, Howard
- Ojo-Amaize, Emmanuel
- Nchekwube, Emeka
- Oyemade, Olusola
|
Abrégé
New uses of hypoestoxide, its derivatives and related compounds for treatment and prevention of neurodegenerative diseases (e.g. Parkinsons disease, Alzheimers disease, Huntingtons disease) are described. More specifically, the invention relates to methods for treating various neurodegenerative diseases through administration of hypoestoxide, its derivatives and related compounds, or a combination thereof to a subject with a neurodegenerative disease such that the symptoms of the disease are treated or at least partially alleviated. Furthermore, the present invention further provides methods of preventing the development of neurodegenerative diseases in individuals who are predisposed to developing a neurodegenerative disease over time.
Classes IPC ?
- A61K 31/336 - Composés hétérocycliques ayant l'oxygène comme seul hétéro-atome d'un cycle, p. ex. fungichromine ayant des cycles à trois chaînons, p. ex. oxirane, fumagilline
- A61P 25/28 - Médicaments pour le traitement des troubles du système nerveux des troubles dégénératifs du système nerveux central, p. ex. agents nootropes, activateurs de la cognition, médicaments pour traiter la maladie d'Alzheimer ou d'autres formes de démence
- C07D 303/02 - Composés contenant des cycles oxirane
|
3.
|
HYPOESTOXIDE, DERIVATIVES, RELATED COMPOUNDS, AND AGONISTS THEREOF FOR TREATMENT OR PREVENTION OF NEURODEGENERATIVE DISEASES
| Numéro d'application |
US2016016294 |
| Numéro de publication |
2016/144441 |
| Statut |
Délivré - en vigueur |
| Date de dépôt |
2016-02-03 |
| Date de publication |
2016-09-15 |
| Propriétaire |
IMMUNE MODULATION, INC. (USA)
|
| Inventeur(s) |
- Cottam, Howard
- Ojo-Amaize, Emmanuel
- Nchekwube, Emeka
- Oyemade, Olusola
|
Abrégé
New uses of hypoestoxide, its derivatives and related compounds for treatment and prevention of neurodegenerative diseases (e.g. Parkinsons disease, Alzheimers disease, Huntingtons disease) are described. More specifically, the invention relates to methods for treating various neurodegenerative diseases through administration of hypoestoxide, its derivatives and related compounds, or a combination thereof to a subject with a neurodegenerative disease such that the symptoms of the disease are treated or at least partially alleviated. Furthermore, the present invention further provides methods of preventing the development of neurodegenerative diseases in individuals who are predisposed to developing a neurodegenerative disease over time.
Classes IPC ?
- A61K 31/336 - Composés hétérocycliques ayant l'oxygène comme seul hétéro-atome d'un cycle, p. ex. fungichromine ayant des cycles à trois chaînons, p. ex. oxirane, fumagilline
- C07D 303/02 - Composés contenant des cycles oxirane
- A61P 25/28 - Médicaments pour le traitement des troubles du système nerveux des troubles dégénératifs du système nerveux central, p. ex. agents nootropes, activateurs de la cognition, médicaments pour traiter la maladie d'Alzheimer ou d'autres formes de démence
|
4.
|
DERIVATIVES OF HYPOESTOXIDES FOR THE TREATMENT OF MALARIA
| Numéro d'application |
US2008012708 |
| Numéro de publication |
2010/056223 |
| Statut |
Délivré - en vigueur |
| Date de dépôt |
2008-11-13 |
| Date de publication |
2010-05-20 |
| Propriétaire |
IMMUNE MODULATION, INC. (USA)
|
| Inventeur(s) |
- Cottam, Howard, B.
- Ojo-Amaize, Emmanuel, A.
- Nchekwube, Emeka, J.
- Oyemade, Olusola, A.
- Nchekwube, Donna, G.
|
Abrégé
Novel diterpene compounds, in particular, hypoestoxide- related compounds, are provided in pure form or as contained in the native plant source, for treatment and prophylaxis of cancer, inflammatory diseases, hyperlipidemias, malaria, and diabetes mellitus. Embodiments also pertain to methods for using the hypoestoxide-related compounds to treat various diseases and symptoms associated with those diseases.
Classes IPC ?
- A61K 31/336 - Composés hétérocycliques ayant l'oxygène comme seul hétéro-atome d'un cycle, p. ex. fungichromine ayant des cycles à trois chaînons, p. ex. oxirane, fumagilline
- A61K 45/06 - Mélanges d'ingrédients actifs sans caractérisation chimique, p. ex. composés antiphlogistiques et pour le cœur
- A61P 33/06 - Antipaludéens
|
|